Facioscapulohumeral muscular dystrophy: consequences of chromatin relaxation.

TitleFacioscapulohumeral muscular dystrophy: consequences of chromatin relaxation.
Publication TypeJournal Article
Year of Publication2012
Authorsvan der Maarel, SM, Miller, DG, Tawil, R, Filippova, GN, Tapscott, SJ
JournalCurr Opin Neurol
Volume25
Issue5
Pagination614-20
Date Published2012 Oct
ISSN1473-6551
KeywordsAnimals, Chromatin, Homeodomain Proteins, Humans, Muscle, Skeletal, Muscular Dystrophy, Facioscapulohumeral, Transcription, Genetic
Abstract

PURPOSE OF REVIEW: In recent years, we have seen remarkable progress in our understanding of the disease mechanism underlying facioscapulohumeral muscular dystrophy (FSHD). The purpose of this review is to provide a comprehensive overview of our current understanding of the disease mechanism and to discuss the observations supporting the possibility of a developmental defect in this disorder.

RECENT FINDINGS: In the majority of cases, FSHD is caused by contraction of the D4Z4 repeat array (FSHD1). This results in local chromatin relaxation and stable expression of the DUX4 retrogene in skeletal muscle, but only when a polymorphic DUX4 polyadenylation signal is present. In some cases (FSHD2), D4Z4 chromatin relaxation and stable DUX4 expression occur in the absence of D4Z4 array contraction. DUX4 is a germline transcription factor and its expression in skeletal muscle leads to activation of early stem cell and germline programs and transcriptional activation of retroelements.

SUMMARY: Recent studies have provided a plausible disease mechanism for FSHD in which FSHD results from inappropriate expression of the germline transcription factor DUX4. The genes regulated by DUX4 suggest several mechanisms of muscle damage, and provide potential biomarkers and therapeutic targets that should be investigated in future studies.

DOI10.1097/WCO.0b013e328357f22d
Alternate JournalCurr. Opin. Neurol.
PubMed ID22892954
PubMed Central IDPMC3653067
Grant ListU54 HG006493 / HG / NHGRI NIH HHS / United States
RC2 HG005608 / HG / NHGRI NIH HHS / United States
P01NS069539 / NS / NINDS NIH HHS / United States
P01 NS069539 / NS / NINDS NIH HHS / United States
HG006493 / HG / NHGRI NIH HHS / United States
R01 AR045203 / AR / NIAMS NIH HHS / United States
UL1 RR024160 / RR / NCRR NIH HHS / United States
R01AR045203 / AR / NIAMS NIH HHS / United States
HG005608 / HG / NHGRI NIH HHS / United States
UM1 HG006493 / HG / NHGRI NIH HHS / United States
UL1RR024160 / RR / NCRR NIH HHS / United States